Skip to search formSkip to main contentSkip to account menu

L 157012

Known as: Butanoic acid, 2,2-dimethyl-, 1,2,3,7,8,8a-hexahydro-3-(hydroxymethyl)-7-methyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha,3beta,7beta,8beta(2S*,4S*),8abeta))-, L-157,012, L-157012 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

Hydroxymethylglutaryl-CoA Reductase InhibitorsLovastatin
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Applications of Oxygen Polarography to Drug Stability Testing and Formulation Development: Solution-Phase Oxidation of Hydroxymethylglutaryl Coenzyme A (HMG-CoA) Reductase Inhibitors
The kinetics of oxidation of the HMG-CoA reductase inhibitors lovastatin, simvastatin, L-157,012, and L-647,318 were studied in… 
1990
1990
Regioselectivity and stereoselectivity in the metabolism of HMG-CoA reductase inhibitors.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)